Old Web
English
Sign In
Acemap
>
authorDetail
>
John Le Gall
John Le Gall
Morgan Stanley Children's Hospital
Medicine
Internal medicine
Oncology
MAC Regimen
Regimen
3
Papers
34
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
544 DELTA-1: A global, multicenter phase 2 study of ITIL-168, an unrestricted autologous tumor-infiltrating lymphocyte (TIL) cell therapy, in adult patients with advanced cutaneous melanoma
2021
Journal for ImmunoTherapy of Cancer
Brian R. Gastman
Omid Hamid
Pippa Corrie
Geoffrey T. Gibney
Gregory A. Daniels
Bartosz Chmielowski
Sajeve S. Thomas
Evidio Domingo-Musibay
Donald P. Lawrence
Yizhou Jiang
Audrey Kennedy
Jeff Aycock
Rubén Álvarez-Rodríguez
Paul D. Robbins
John Le Gall
Zachary J. Roberts
Robert E. Hawkins
Amod A. Sarnaik
Show All
Source
Cite
Save
Citations (0)
ZUMA-19: A Phase 1/2 Multicenter Study of Lenzilumab Use With Axicabtagene Ciloleucel (Axi-Cel) in Patients (Pts) With Relapsed or Refractory Large B Cell Lymphoma (R/R LBCL)
2020
Blood
Saad S. Kenderian
Olalekan O. Oluwole
Philip L. McCarthy
Ran Reshef
Parveen Shiraz
Omar H. Ahmed
John Le Gall
Myrna R. Nahas
Lily Tang
Sattva S. Neelapu
Show All
Source
Cite
Save
Citations (3)
A Phase I Study of Gemtuzumab Ozogamicin (GO) in Combination with Busulfan and Cyclophosphamide (Bu/Cy) and Allogeneic Stem Cell Transplantation in Children with Poor-Risk CD33+ AML: A New Targeted Immunochemotherapy Myeloablative Conditioning (MAC) Regimen
2012
Biology of Blood and Marrow Transplantation
Prakash Satwani
Monica Bhatia
James Garvin
D. George
Filemon Dela Cruz
John Le Gall
Zhezhen Jin
Joseph Schwartz
Deirdre Duffy
Carmella van de Ven
Sandra Foley
R. Hawks
Erin Morris
Lee Ann-Baxter-Lowe
Mitchell S. Cairo
Show All
Source
Cite
Save
Citations (31)
1